Xueli Zhu Phones & Addresses
-
15170 Sapling Ridge Dr, Dayton, MD 21036 (443) 535-8395
-
Clarksville, MD
-
Warren, NJ
-
Iselin, NJ
-
Newark, NJ
-
20 Crosswood Way, Warren, NJ 07059 (908) 268-9750
Work
Position:
Food Preparation and Serving Related Occupations
Education
Degree:
Associate degree or higher
Publications
Us Patents
Production Of Biologically Active Polypeptides By Treatment With An Exogenous Peptide Sequence
View pageUS Patent:
51910632, Mar 2, 1993
Filed:
May 2, 1989
Appl. No.:
7/346552
Inventors:
Masayori Inouye - Bridgewater NJ
Yoshiji Ohta - Highland Park NJ
Xueli Zhu - Iselin NJ
Frank Jordan - Chatham NJ
Yoshiji Ohta - Highland Park NJ
Xueli Zhu - Iselin NJ
Frank Jordan - Chatham NJ
Assignee:
University of Medicine and Dentistry of New Jersey - NJ
International Classification:
C07K 300
C07K 1300
C12N 900
C07K 1300
C12N 900
US Classification:
530324
Abstract:
A method of making a biologically inactive polypeptide active is disclosed. Activity is imparted to the polypeptide through treatment with an exogenous peptide sequence. The nature of the exogenous peptide sequence is disclosed.
Simple And Efficient Method For Site-Directed Mutageneis With Double-Stranded Plasmid Dna
View pageUS Patent:
56331576, May 27, 1997
Filed:
Feb 15, 1996
Appl. No.:
8/601698
Inventors:
Sidney Pestka - North Caldwell NJ
Derhsing Lai - East Brunswick NJ
Xueli Zhu - Iselin NJ
Derhsing Lai - East Brunswick NJ
Xueli Zhu - Iselin NJ
Assignee:
University of Medicine & Dentistry of New Jersey - Newark NJ
International Classification:
C12N 1509
C12N 1501
C12N 1501
US Classification:
4351723
Abstract:
This invention relates to a method for preparing site-specific mutations in double-stranded plasmid DNA which comprises the steps of (a) double digesting a plasmid having a site A, which contains a target sequence, and sites B and C, which flank site A, with restriction endonucleases A and B to produce fragment I and with restriction endonucleases A and C to produce fragment II, wherein restriction endonuclease A produces a 3' or 5' overhang; (b) denaturating fragments I and II to form a mixture; (c) reannealing the mixture from step (b) to produce parental homoduplex fragments I and II, heteroduplex fragment III, and heteroduplex fragment IV; (d) extending the 3' ends of the heteroduplex fragments; and (e) ligating the heteroduplex fragments to produce the double-stranded plasmid DNA mutant.